Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture
Journal of Clinical Medicine · 05.06.2024 · 13 (11) · 3324
DOI: 10.3390/jcm13113324 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.06.2024. Verfasst von Alex Crane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Management of intracranial aneurysms (IAs) is determined by patient age, risk of rupture, and comorbid conditions. While endovascular and microsurgical interventions offer solutions to mitigate the risk of rupture, pharmacological management strategies may complement these approaches or serve as alternatives in appropriate cases. The pathophysiology of IAs allows for the targeting of inflammation to prevent the development and rupture of IAs. The aim of this review is to provide an updated summary of different pharmaceutical management strategies for IAs. Acetylsalicylic acid and renin-angiotensin-aldosterone system (RAAS) inhibitor antihypertensives have some evidence supporting their protective effect. Studies of selective cyclooxygenase-2 (COX-2) inhibitors, statins, ADP inhibitors, and other metabolism-affecting drugs have demonstrated inconclusive findings regarding their association with aneurysm growth or rupture. In this manuscript, we highlight the evidence supporting each drug’s effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Department of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.
ORCID-Profile: Alex Crane, Regan M Shanahan, Zachary C Gersey
Zitieren
APA
Crane, A., Shanahan, R. M., Hudson, J. S., Nowicki, K. W., Gersey, Z. C., Agarwal, P., Jacobs, R. C., Lang, M. J., & Gross, B. (2024). Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture. Journal of Clinical Medicine, 13(11), 3324. https://doi.org/10.3390/jcm13113324
Vancouver
Crane A, Shanahan RM, Hudson JS, Nowicki KW, Gersey ZC, Agarwal P, et al. Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture. Journal of Clinical Medicine. 2024;13(11):3324. doi:10.3390/jcm13113324
BibTeX
@article{Crane2024,
author = {Crane, Alex and Shanahan, Regan M and Hudson, Joseph S and Nowicki, Kamil W and Gersey, Zachary C and Agarwal, Prateek and Jacobs, Rachel C and Lang, Michael J and Gross, Bradley},
title = {Pharmaceutical Modulation of Intracranial Aneurysm Development and Rupture},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {11},
pages = {3324},
doi = {10.3390/jcm13113324}
}
EUVIMED